Efficacy of l‐Arginine treatment in patients with HTLV‐1‐associated neurological disease
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.51715
Abstract: HTLV‐1 infection causes HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP), resulting in loss of motor function. In this Phase 2 trial, we assessed the efficacy and safety of l‐arginine in patients with HAM/TSP. read more here.
Keywords: treatment patients; htlv associated; efficacy arginine; efficacy ... See more keywords
Cerebral and spinal cord changes observed through magnetic resonance imaging in patients with HTLV-1–associated myelopathy/tropical spastic paraparesis: a systematic review
Sign Up to like & getrecommendations! Published in 2022 at "Journal of NeuroVirology"
DOI: 10.1007/s13365-021-01043-2
Abstract: To verify brain and spinal changes using magnetic resonance imaging in patients with HTLV-1–associated myelopathy/tropical spastic paraparesis. This was a systematic review. The descriptors used were tropical spastic paraparesis and magnetic resonance image. The keyword… read more here.
Keywords: htlv associated; spastic paraparesis; tropical spastic; associated myelopathy ... See more keywords
Making Visible HTLV Infection in a Non-endemic Area of Argentina
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.892159
Abstract: In Argentina, the human T-cell lymphotropic virus type 1 (HTLV-1) infection has been documented mainly among blood banks with a prevalence of ~0.02–0.046% for Buenos Aires city, 0.8% for the northeast, and 1% for the… read more here.
Keywords: htlv infection; endemic area; infection; patients htlv ... See more keywords